BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35956315)

  • 1. Activated Protein C Ameliorates Tubular Mitochondrial Reactive Oxygen Species and Inflammation in Diabetic Kidney Disease.
    Rana R; Manoharan J; Gupta A; Gupta D; Elwakiel A; Khawaja H; Fatima S; Zimmermann S; Singh K; Ambreen S; Gadi I; Biemann R; Jiang S; Shahzad K; Kohli S; Isermann B
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney Disease.
    Gupta A; Singh K; Fatima S; Ambreen S; Zimmermann S; Younis R; Krishnan S; Rana R; Gadi I; Schwab C; Biemann R; Shahzad K; Rani V; Ali S; Mertens PR; Kohli S; Isermann B
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc.
    Bock F; Shahzad K; Wang H; Stoyanov S; Wolter J; Dong W; Pelicci PG; Kashif M; Ranjan S; Schmidt S; Ritzel R; Schwenger V; Reymann KG; Esmon CT; Madhusudhan T; Nawroth PP; Isermann B
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):648-53. PubMed ID: 23267072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DsbA-L deficiency exacerbates mitochondrial dysfunction of tubular cells in diabetic kidney disease.
    Gao P; Yang M; Chen X; Xiong S; Liu J; Sun L
    Clin Sci (Lond); 2020 Apr; 134(7):677-694. PubMed ID: 32167139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
    Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
    Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
    Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
    Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
    Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
    Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
    Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
    Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adropin Carried by Reactive Oxygen Species-Responsive Nanocapsules Ameliorates Renal Lipid Toxicity in Diabetic Mice.
    Yu M; Wang D; Zhong D; Xie W; Luo J
    ACS Appl Mater Interfaces; 2022 Aug; 14(33):37330-37344. PubMed ID: 35951354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of TLR4 on PGC-1
    Yuan S; Liu X; Zhu X; Qu Z; Gong Z; Li J; Xiao L; Yang Y; Liu H; Sun L; Liu F
    Oxid Med Cell Longev; 2018; 2018():6296802. PubMed ID: 29861832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in diabetic kidney disease.
    Wei PZ; Szeto CC
    Clin Chim Acta; 2019 Sep; 496():108-116. PubMed ID: 31276635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease.
    Zhan M; Usman IM; Sun L; Kanwar YS
    J Am Soc Nephrol; 2015 Jun; 26(6):1304-21. PubMed ID: 25270067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease.
    Shahzad K; Fatima S; Al-Dabet MM; Gadi I; Khawaja H; Ambreen S; Elwakiel A; Klöting N; Blüher M; Nawroth PP; Mertens PR; Michel S; Jaschinski F; Klar R; Isermann B
    J Am Soc Nephrol; 2021 Dec; 32(12):3066-3079. PubMed ID: 34479965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
    Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
    Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.
    Tan SM; Ziemann M; Thallas-Bonke V; Snelson M; Kumar V; Laskowski A; Nguyen TV; Huynh K; Clarke MV; Libianto R; Baker ST; Skene A; Power DA; MacIsaac RJ; Henstridge DC; Wetsel RA; El-Osta A; Meikle PJ; Wilson SG; Forbes JM; Cooper ME; Ekinci EI; Woodruff TM; Coughlan MT
    Diabetes; 2020 Jan; 69(1):83-98. PubMed ID: 31624141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice.
    Tachibana H; Ogawa D; Sogawa N; Asanuma M; Miyazaki I; Terami N; Hatanaka T; Horiguchi CS; Nakatsuka A; Eguchi J; Wada J; Yamada H; Takei K; Makino H
    Am J Physiol Renal Physiol; 2014 Jan; 306(1):F105-15. PubMed ID: 24154695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease.
    Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J
    Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition.
    Wu Z; Li D; Tian D; Liu X; Wu Z
    PLoS One; 2022; 17(12):e0279010. PubMed ID: 36516169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGC-1α ameliorates kidney fibrosis in mice with diabetic kidney disease through an antioxidative mechanism.
    Zhang L; Liu J; Zhou F; Wang W; Chen N
    Mol Med Rep; 2018 Mar; 17(3):4490-4498. PubMed ID: 29344670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
    Falkevall A; Mehlem A; Palombo I; Heller Sahlgren B; Ebarasi L; He L; Ytterberg AJ; Olauson H; Axelsson J; Sundelin B; Patrakka J; Scotney P; Nash A; Eriksson U
    Cell Metab; 2017 Mar; 25(3):713-726. PubMed ID: 28190774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.